Thiazolidine - CAS 504-78-9
Catalog: |
BB027070 |
Product Name: |
Thiazolidine |
CAS: |
504-78-9 |
Synonyms: |
1,3-thiazolidine |
IUPAC Name: | 1,3-thiazolidine |
Description: | Thiazolidine (CAS# 504-78-9) is a useful research chemical. |
Molecular Weight: | 89.16 |
Molecular Formula: | C3H7NS |
Canonical SMILES: | C1CSCN1 |
InChI: | InChI=1S/C3H7NS/c1-2-5-3-4-1/h4H,1-3H2 |
InChI Key: | OGYGFUAIIOPWQD-UHFFFAOYSA-N |
Boiling Point: | 72-75 °C (25 torr) |
Purity: | 98 % |
Density: | 1.131 g/cm3 |
Appearance: | Clear colorless liquid |
MDL: | MFCD00005211 |
LogP: | 0.60910 |
GHS Hazard Statement: | H226 (100%): Flammable liquid and vapor [Warning Flammable liquids] |
Precautionary Statement: | P210, P233, P240, P241, P242, P243, P280, P303+P361+P353, P370+P378, P403+P235, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-111943946-A | Dihydroquinazinone carboxylic acid compound containing nitrogen heterocyclic segment and application thereof | 20200819 |
WO-2021206876-A1 | Inhibitors of norovirus and coronavirus replication | 20200410 |
WO-2021204800-A1 | Difluorocyclohexyl derivatives as il-17 modulators | 20200407 |
WO-2021204801-A1 | Difluorocyclohexyl derivatives as il-17 modulators | 20200407 |
WO-2021197574-A1 | Rel/rela/spot small molecules modulators and screening methods | 20200330 |
PMID | Publication Date | Title | Journal |
32639145 | 20200817 | Teneligliptin Promotes Bile Acid Synthesis and Attenuates Lipid Accumulation in Obese Mice by Targeting the KLF15-Fgf15 Pathway | Chemical research in toxicology |
32761301 | 20200801 | The AKR1B1 inhibitor epalrestat suppresses the progression\xa0of cervical cancer | Molecular biology reports |
32547320 | 20200101 | AKR1B10 Inhibitor Epalrestat Facilitates Sorafenib-Induced Apoptosis and Autophagy Via Targeting the mTOR Pathway in Hepatocellular Carcinoma | International journal of medical sciences |
30503936 | 20190201 | Discovery of N1-(4-((7-(3-(4-ethylpiperazin-1-yl)propoxy)-6-methoxyquinolin-4-yl)oxy)-3,5-difluorophenyl)-N3-(2-(2,6-difluorophenyl)-4-oxothiazolidin-3-yl)urea as a multi-tyrosine kinase inhibitor for drug-sensitive and drug-resistant cancers treatment | European journal of medicinal chemistry |
30247908 | 20181108 | Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic Properties | Journal of medicinal chemistry |
Complexity: | 30.1 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 89.0299204 |
Formal Charge: | 0 |
Heavy Atom Count: | 5 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 89.0299204 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 37.3 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Oxazole/Thiazole
Thiazolines/Thiazolidines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS